Medications

COVID study examines efficacy of immune regulating drug

Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.

Medications

Study says inhalers OK to use amid COVID-19 concerns

The benefits of using inhalers and nebulisers containing steroids outweigh the risks despite warnings to the contrary during the COVID-19 pandemic, a study by University of Huddersfield researchers has found.

Immunology

B cells and their function in the immune system

Whenever a germ gets into the human body, the immune system usually responds immediately to fight off the enemy attacker. One of our defense system's most important strategies involves B lymphocytes, also known as B cells, ...

Other

EU approves merger of Pfizer off-patent unit and Mylan

The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.

Diseases, Conditions, Syndromes

COVID-19 context clues: Social factors shape the curve

In the early months of the COVID-19 pandemic, markedly different scenarios played out in countries around the world. In northern Italy, the viral disease spread quickly and overwhelmed one of the world's most developed health ...

page 11 from 35